These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 14720059
21. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids. Zisman DA, Lynch JP, Toews GB, Kazerooni EA, Flint A, Martinez FJ. Chest; 2000 Jun; 117(6):1619-26. PubMed ID: 10858393 [Abstract] [Full Text] [Related]
23. [Idiopathic lung fibrosis]. Schmid-Zumstein A, Bernheim R, Medici TC. Schweiz Med Wochenschr; 1988 Jun 25; 118(25):979-85. PubMed ID: 3045952 [Abstract] [Full Text] [Related]
24. [Long term development of idiopathic pulmonary fibrosis. Combined therapy with immunodepressors, D-penicillamine and corticosteroids]. Meier-Sydow J, Connette B, Hübel E, Kroidl RF, Kronenberger H, Müller U, Rust M, Thiel C. Bronchopneumologie; 1979 Jun 25; 29(3):249-54. PubMed ID: 509328 [No Abstract] [Full Text] [Related]
25. [Idiopathic pulmonary fibrosis; description of a Dutch cohort]. Barlo NP, van Moorsel CH, van den Bosch JM, van de Graaf EA, Kwakkel-van Erp JM, Grutters JC. Ned Tijdschr Geneeskd; 2009 Jun 25; 153():B425. PubMed ID: 19785823 [Abstract] [Full Text] [Related]
26. Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role? Luppi F, Cerri S, Richeldi L. Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec 25; 22 Suppl 1():S74-84. PubMed ID: 16457019 [Abstract] [Full Text] [Related]
27. [Treatment of idiopathic pulmonary fibrosis]. Dury S. Rev Mal Respir; 2006 Apr 25; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517 [No Abstract] [Full Text] [Related]
28. Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach. Nathan SD. Clin Chest Med; 2006 Mar 25; 27(1 Suppl 1):S27-35, vi. PubMed ID: 16545630 [Abstract] [Full Text] [Related]
29. Pharmacotherapeutic management of pulmonary sarcoidosis. Fazzi P. Am J Respir Med; 2003 Mar 25; 2(4):311-20. PubMed ID: 14719997 [Abstract] [Full Text] [Related]
30. [Pulmonary fibrosis. Classification, diagnosis, therapy]. Costabel U, Guzman J. Internist (Berl); 2003 Jun 25; 44 Suppl 1():S35-43. PubMed ID: 14567087 [Abstract] [Full Text] [Related]
33. Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Antoniu SA. Expert Opin Investig Drugs; 2006 Jul 25; 15(7):823-8. PubMed ID: 16787145 [Abstract] [Full Text] [Related]
34. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids. Pereira CA, Malheiros T, Coletta EM, Ferreira RG, Rubin AS, Otta JS, Rocha NS. Respir Med; 2006 Feb 25; 100(2):340-7. PubMed ID: 16002271 [Abstract] [Full Text] [Related]
35. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment]. Behr J. Dtsch Med Wochenschr; 2012 Mar 25; 137(12):601-4. PubMed ID: 22415624 [Abstract] [Full Text] [Related]
36. New perspectives in the treatment of idiopathic pulmonary fibrosis. Rogliani P, Mura M, Assunta Porretta M, Saltini C. Ther Adv Respir Dis; 2008 Apr 25; 2(2):75-93. PubMed ID: 19124361 [Abstract] [Full Text] [Related]
37. New developments in the therapy of pulmonary fibrosis. Scriabine A, Rabin DU. Adv Pharmacol; 2009 Apr 25; 57():419-64. PubMed ID: 20230768 [Abstract] [Full Text] [Related]